TY  - GEN
TI  - Multiple myeloma  patients experience high  response rate with new  three-drug combination
SN  - 1555-8576
PY  - 2010///0806
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Bone Marrow
KW  - pathology
KW  - Boronic Acids
KW  - administration & dosage
KW  - Bortezomib
KW  - Clinical Trials, Phase I as Topic
KW  - Clinical Trials, Phase II as Topic
KW  - Dexamethasone
KW  - Disease-Free Survival
KW  - Drug Administration Schedule
KW  - Humans
KW  - Lenalidomide
KW  - Leukocytes
KW  - Multicenter Studies as Topic
KW  - Multiple Myeloma
KW  - drug therapy
KW  - Pyrazines
KW  - Stem Cell Transplantation
KW  - Thalidomide
KW  - Treatment Outcome
N1  - Publication Type: News
UR  - https://doi.org/10.4161/cbt.8.24.11003
ER  -